Pfizer offers a 6.7% dividend yield, trading at a low valuation with resilient drug portfolio growth. Realty Income Corp. has ...

Pfizer has terminated a Phase I trial of its investigational STING therapy in advanced solid tumors, according to an update ...

Pfizer is ranked third among the best pharma stocks to buy according to hedge funds. The company boasts a strong oncology ...

Guggenheim analyst Vamil Divan maintained a Buy rating on Pfizer (PFE – Research Report) yesterday. The company’s shares closed yesterday at ...

We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to ...

Discover the strengths & weaknesses of healthcare giants Johnson & Johnson and Pfizer. Find out which stock is more promising ...

One of Pfizer’s largest deals has been the acquisition of Seagen in 2023 for $43 billion. And from the looks of it, this may very well be the deal reviving Pfizer’s fortunes. In response to ...

Conservative commentator Megyn Kelly claimed the Pfizer COVID vaccine left her with ... in the early stages and that such negative side effects were found only in a “very small percentage ...

The former head of the Food and Drug Administration’s (FDA) drug division is joining Pfizer as its chief medical officer, the company announced Monday. Patrizia Cavazzoni was formerly director ...

Dansey, who has retired, had taken on the interim role after Pfizer’s former R&D head and Chief Scientific Officer Mikael Dolsten, M.D., Ph.D., retired in November, triggering a domino effect of ...

Vedotin is the payload in a clutch of ADCs that Pfizer acquired in the Seagen buyout, including the approved products Adcetris, Padcev and Tivdak. Summit's stock price dropped by nearly 15% during ...